|1.||Qin, Haina: 3 articles (02/2015 - 10/2008)|
|2.||Song, Jianxing: 3 articles (02/2015 - 10/2008)|
|3.||Pasquale, Elena B: 3 articles (10/2013 - 10/2008)|
|4.||Nakamura, Toru: 2 articles (12/2015 - 11/2006)|
|5.||Boyd, Andrew W: 2 articles (01/2013 - 09/2012)|
|6.||Turnley, Ann M: 2 articles (01/2013 - 09/2012)|
|7.||Dixon, Kirsty J: 2 articles (01/2013 - 09/2012)|
|8.||Munro, Kathryn M: 2 articles (01/2013 - 09/2012)|
|9.||Noberini, Roberta: 2 articles (07/2012 - 10/2008)|
|10.||Figueroa, Johnny D: 2 articles (05/2007 - 12/2006)|
|1.||Spinal Cord Injuries (Spinal Cord Injury)
09/06/2012 - "In a previous study we found that the EphA4 receptor inhibits regeneration following spinal cord injury by blocking regrowth of axons and regulation of astrocyte reactivity. "
06/15/2013 - "We have previously shown that genetic deletion or competitive antagonism of EphA4 receptor activity promotes axonal regeneration and functional recovery in a mouse model of lateral hemisection spinal cord injury. "
05/11/2007 - "Reduction of EphA4 receptor expression after spinal cord injury does not induce axonal regeneration or return of tcMMEP response."
10/24/2008 - "The EphA4 receptor plays important roles in the inhibition of the regeneration of injured axons, synaptic plasticity, platelet aggregation, and likely in certain types of cancer. "
11/01/2006 - "EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth."
02/20/2015 - "Additional to involvement in diverse physiological and pathological processes such as axon regeneration, synaptic plasticity, and cancers, EphA4 receptor has been recently identified as the only amyotrophic lateral sclerosis (ALS) modifier. "
01/01/2013 - "The EphA4 receptor tyrosine kinase regulates a variety of physiological and pathological processes during neural development and the formation of tumor blood vessels; thus, it represents a new and promising therapeutic target. "
07/01/2012 - "The EphA4 receptor tyrosine kinase interacts with ephrin ligands to regulate many processes, ranging from axon guidance and nerve regeneration to cancer malignancy. "
|1.||Ephrin-A3 (Ephrin A3)
|2.||Actins (F Actin)
|3.||enhanced green fluorescent protein
|4.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|6.||Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
|7.||Ephrin-A1 (Ephrin A1)